Why Is Inspire (INSP) Down 2.4% Since Last Earnings Report?

Core Insights - Inspire Medical Systems reported a strong fourth-quarter performance with adjusted earnings per share of $1.65, reflecting a 43.5% year-over-year increase and surpassing the Zacks Consensus Estimate by 139.1% [3] - Revenue for the fourth quarter reached $269.1 million, a 10.5% increase year-over-year, aligning with the Zacks Consensus Estimate [4] - The company has revised its revenue guidance for 2026 down to $950 million-$1 billion, indicating a growth of 4-10% from 2025 levels, while the adjusted earnings per share outlook is set between $1.85-$2.35 [8] Financial Performance - Gross profit for the fourth quarter increased by 14.4% year-over-year to $233 million, with gross margin expanding by 160 basis points to 86.6% [5] - Operating profit decreased by 44.6% year-over-year to $46.1 million, although the operating margin improved by nearly 380 basis points to 17.1% [6] - As of the end of the fourth quarter, the company had cash and cash equivalents of $404.6 million, up from $322.6 million at the end of the third quarter [7] Market Position and Outlook - The consensus estimates for Inspire Medical have shown a downward trend, with a significant shift of -5200% noted [10] - The company holds a Zacks Rank of 3 (Hold), suggesting an expectation of an in-line return in the coming months [12] - In comparison, Hinge Health Inc., a competitor in the same industry, reported stable revenues and a Zacks Rank of 2 (Buy), indicating a more favorable outlook [13][14]